Effect of selective COX-2 inhibitor and PGE1 on the expression of VEGF and CTGF in cirrhotic rats

涂传涛,王吉耀,郭津生
DOI: https://doi.org/10.3969/j.issn.1006-5709.2009.01.020
2009-01-01
Abstract:Objective To assess the effect of selective Cyclooxygenase-2(COX-2) inhibitor,and PGE1 on the expression of vascular endothelial growth factor(VEGF) and connective tissue growth factor(CTGF) in cirrhotic rats.Methods Fifty-two male Sprague-Dawley rats were used.Cirrhosis was induced by CCl4(CCl4/olive oil:v/v=1/1) twice a week for 8 weeks.Rats in the control group(n=10) received olive oil only;CCl4 treated rats were divided into three groups: the model group (n=14) in which placebo(saline solution by gavage) was administered,rofecoxib(10 mg·kg-1·d-1 by gavage) group(n=14) and misoprostol(10 μg·d-1 by gavage) group(n=14).The CTGF and VEGF protein levels and their localization in the liver were determined by Western blot and immunohistochemistry,respectively.Results The protein levels of VEGF and CTGF both elevated in the liver of rats treated with CCl4.Compared with placebo,protein expressions of VEGF and CTGF were both significantly suppressed by rofecoxib treatment,while CTGF protein level decreased and VEGF protein level did not alter in the misoprostol group liver.Conclusion As liver fibrogenesis progressing,both VEGF and CTGF increased in liver,but the selective COX-2 inhibitor,rofecoxib may inhibit these increase.This may be the molecular basis of the COX-2 inhibitor to ameliorate hepatic fibrosis.
What problem does this paper attempt to address?